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Background
Zinc is a micronutrient which is essential for human
health, playing a role as a cofactor of enzymes such as
dehydrogenases, peptidases and component of zinc finger
domains. In organism zinc is involved in metabolic path-
ways, immune processes, maintaining ion balance between
other elements. Recently, it has been reported that zinc
may play role in chemoprevention, and its level may be
associated with occurrence of cancers.
Aim of the study
The aim of the study was to evaluate a possible correlation
between serum Zn level and occurrence of prostate, color-
ectal and laryngeal cancers. This will allow to determine
whether serum Zn level may be used as an indicator
which patients should be subjected for further cancer
diagnostics.
Material and methods
The study has been conducted in 3 groups: 197 prostate
cancer cases and 197 controls, 101 colorectal cancer cases
and 101 controls, 109 laryngeal cancer cases and 109
controls.
Zinc level in serum was measured in all individuals by
inductively coupled plasma mass spectrometry (ICP-MS)
using Elan DRC-e ICP-Mass Spectrometer, Perkin Elmer.
After obtaining results from mass spectrometry, indivi-
duals in each group were divided into 4 quartiles. Compar-
ison of number of cases and controls was performed in
each quartile. Risk of cancer occurrence was evaluated
with regards to the reference category - the lowest zinc
level.
Results
We have observed that high serum Zn level (>991 µg/l)
was associated with higher incidence of prostate cancers
(OR = 2.43; p < 0.003; CI 1.370 - 4.309). In contrast, high
level of Zn (>959 µg/l) was associated with decreased
incidence of laryngeal cancers (OR = 0.08; p < 0.0001;
CI 0.03122 - 0.1918). In group of colorectal cancers we
have not found any correlation between Zn level and
cancer occurrence.
Conclusions
Results of our study suggest that high level of Zn may be
an indicator for prostate examination (ex. PSA, biopsy)
and low level of Zn may be an indicator for laryngeal
examination. Serum Zn level assessment may improve
cancer screening by suggesting which patients should be
subjected for further testing. Such procedure may increase
early detection of cancer. Our results seem to be promis-
ing and the study will be also conducted in groups of
breast and lung cancers.
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